ARQT Q2 2022 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ARQTArcutis Biotherapeutics, Inc.

$3B

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$234,000

Operating Income

-$66M

Net Income

-$67M

EPS (Diluted)

$-1.34

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$62M

Free Cash Flow

-$62M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$300M

Total Liabilities

$105M

Stockholders' Equity

$195M

Cash & Equivalents

$62M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$234,000	-$182,000	-28.6%
Operating Income	-$66M	-$42M	-56.4%
Net Income	-$67M	-$42M	-60.5%